Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 42 páginas
Examen

PHARMACOTHERAPEUTICS FOR NURSE PRACTITIONER PRESCRIBERS FINAL EXAM PAPER 2026 COMPLETE ANSWERS VERIFIED

Document preview thumbnail
Vista previa 4 fuera de 42 páginas

PHARMACOTHERAPEUTICS FOR NURSE PRACTITIONER PRESCRIBERS FINAL EXAM PAPER 2026 COMPLETE ANSWERS VERIFIED

Vista previa del contenido

PHARMACOTHERAPEUTICS FOR NURSE
PRACTITIONER PRESCRIBERS FINAL EXAM
PAPER 2026 COMPLETE ANSWERS VERIFIED

◉ What is the goal of a patient-centered approach in APRN
prescribing? Answer: The goal is to achieve the best therapy that is
least invasive, least expensive, and least likely to cause adverse
reactions.


◉ What is the significance of evaluating drug information sources?
Answer: Evaluating sources for bias, currency, relevance, and
research validity ensures that APRNs make informed prescribing
decisions.


◉ How do APRNs integrate alternative therapies into their
prescribing practices? Answer: APRNs review alternative therapies,
including lifestyle changes and non-pharmacological approaches,
alongside pharmacological options.


◉ What are the two types of nonadherence to medication? Answer:
Intentional (e.g., perceived ineffectiveness, adverse reactions, cost)
and unintentional (e.g., forgetfulness, lack of knowledge, cognitive
impairment).

,◉ What are some barriers to medication adherence? Answer:
Barriers include asymptomatic or chronic conditions, cognitive
impairment, psychiatric illness, complex regimens, and financial
strain.


◉ What strategies can improve medication adherence? Answer:
Strategies include patient education, regimen simplification, support
mechanisms, addressing barriers, and strategic scheduling.


◉ What is the role of patient education in improving adherence?
Answer: It involves high-quality communication, the 'teach-back'
method, simple language, family involvement, addressing knowledge
deficits, motivational interviewing, and technology use.


◉ How can regimen simplification enhance adherence? Answer: By
using fixed-dose combinations and once-daily dosing.


◉ What are some support mechanisms to improve adherence?
Answer: Early phone contacts, smartphone apps, text messaging,
and personalized drug schedules integrated with daily routines.


◉ What are some ways to address barriers to adherence? Answer:
Anticipating sensory/mobility challenges, leveraging longer-acting
drugs, using reinforcements, involving caregivers, and identifying
financial assistance programs.

,◉ What does strategic scheduling involve in the context of
medication adherence? Answer: Aligning follow-up visits with drug
regimens or lab work and promoting 'one-stop shopping' for care
and refills.


◉ What methods can be used to measure medication adherence?
Answer: Patient reports, clinical outcomes, pill counts, refill records,
and validated scales like the Medication Adherence Questionnaire
(MAQ).


◉ What factors are predictors of medication adherence? Answer:
General health, medical history, life goals, medication history,
comorbidities, social stability, employment status, health beliefs,
cultural background, family/social support, and educational
background.


◉ What is pharmacology? Answer: The study of drugs and their
actions, where a drug is any chemical substance producing a
measurable biological response.


◉ What defines ideal drug properties? Answer: Convenient
administration, single desired action, no unwanted effects,
convenient duration, and improved quality of life.

, ◉ What are the stages of drug development? Answer: Preclinical
stage, clinical stage (Phase I, II, III), and postmarketing surveillance.


◉ What occurs during the preclinical stage of drug development?
Answer: Identification of promising drug targets and extensive
testing in cells, isolated tissues, and animals to establish safety.


◉ What is the focus of Phase I clinical trials? Answer: Establishing
biological effects, safe dosages, and pharmacokinetics in a small
number of healthy patients.


◉ What is the goal of Phase II clinical trials? Answer: To treat
disease in a small number of patients to establish potential for
improving outcomes.


◉ What is the purpose of Phase III clinical trials? Answer: To
compare the new drug to standard therapy in a larger patient
population, aiming for equivalence or superiority.


◉ What is postmarketing surveillance? Answer: Continuous
monitoring after FDA approval where health professionals report
adverse events.

Información del documento

Subido en
28 de febrero de 2026
Número de páginas
42
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$12.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
FocusFile7
3.9
(24)
Vendido
222
Seguidores
3
Artículos
55240
Última venta
3 horas hace


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes